---
figid: PMC9634730__fonc-12-1018333-g001
figtitle: Targeting the regulation of aberrant protein production pathway in gastrointestinal
  cancer treatment
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9634730
filename: fonc-12-1018333-g001.jpg
figlink: /pmc/articles/PMC9634730/figure/f1/
number: F1
caption: The role of endogenous immune stimulatory noncoding RNA 7SL1 in the pathway
  for the regulation of the aberrant protein production (RAPP) and its possible application
  in cancer therapy. (A) Transcriptional regulation of 7SL1 and the downstream mechanism
  for tumor suppressor tumor protein P53 (TP53). MYC, proto-oncogene, basic helix-loop-helix
  (BHLH) transcription factor (MYC); FOXP3, forkhead box P3; PRC2, polycomb repression
  complex 2; SUZ12, SUZ12 polycomb repressive complex 2 subunit; EZH2, enhancer of
  zeste 2 polycomb repressive complex 2 subunit; Pol II, RNA polymerase II; Pol III,
  RNA polymerase III; SRP, signal recognition particle; RIG-1, retinoic acid-inducible
  gene 1 protein; MDA5, melanoma differentiation-associated gene 5; HuR, embryonic
  lethal, abnormal vision, Drosophila (ELAV)-like 1, Hu antigen R. (B) Although the
  unshielded 7SL1-mediated stimulation of tumor tissues can result in disease progression,
  the exosomal delivery of 7SL1 or its combination with engineering chimeric antigen
  receptor (CAR)-T cells can stimulate an anti-tumor effect and lead to a favorable
  disease outcome. Ag, antigen.
papertitle: Targeting the regulation of aberrant protein production pathway in gastrointestinal
  cancer treatment.
reftext: Hiromichi Sato, et al. Front Oncol. 2022;12:1018333.
year: '2022'
doi: 10.3389/fonc.2022.1018333
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: SRP | RAPP | 7SL1 | therapy | gastrointestinal cancer
automl_pathway: 0.9540657
figid_alias: PMC9634730__F1
figtype: Figure
redirect_from: /figures/PMC9634730__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9634730__fonc-12-1018333-g001.html
  '@type': Dataset
  description: The role of endogenous immune stimulatory noncoding RNA 7SL1 in the
    pathway for the regulation of the aberrant protein production (RAPP) and its possible
    application in cancer therapy. (A) Transcriptional regulation of 7SL1 and the
    downstream mechanism for tumor suppressor tumor protein P53 (TP53). MYC, proto-oncogene,
    basic helix-loop-helix (BHLH) transcription factor (MYC); FOXP3, forkhead box
    P3; PRC2, polycomb repression complex 2; SUZ12, SUZ12 polycomb repressive complex
    2 subunit; EZH2, enhancer of zeste 2 polycomb repressive complex 2 subunit; Pol
    II, RNA polymerase II; Pol III, RNA polymerase III; SRP, signal recognition particle;
    RIG-1, retinoic acid-inducible gene 1 protein; MDA5, melanoma differentiation-associated
    gene 5; HuR, embryonic lethal, abnormal vision, Drosophila (ELAV)-like 1, Hu antigen
    R. (B) Although the unshielded 7SL1-mediated stimulation of tumor tissues can
    result in disease progression, the exosomal delivery of 7SL1 or its combination
    with engineering chimeric antigen receptor (CAR)-T cells can stimulate an anti-tumor
    effect and lead to a favorable disease outcome. Ag, antigen.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Myc
  - Polr2A
  - Prim1
  - PolA1
  - PolA2
  - sv
  - Prim2
  - srp
  - Su(z)12
  - E(z)
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - CarT
  - Low
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - MYC
  - ERVW-4
  - FOXP3
  - UCN2
  - EED
  - EZH1
  - EZH2
  - SUZ12
  - RIGI
  - IFIH1
  - ELAVL1
  - TP53
  - CARTPT
  - CD8A
  - CD8B
  - cancer
---
